DeepMed Research

BIOMERIEUX SA

🇫🇷France

Country: 🇫🇷France

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

VIDAS® TBI Real Life Performance in Subjects with Mild Traumatic Brain Injury (mTBI)

Not Applicable

Recruiting

Conditions: Mild Traumatic Brain Injury

Interventions: Diagnostic Test: VIDAS® TBI Test [GFAP and UCH-L1 assays]

First Posted Date: 2024-06-07

Last Posted Date: 2024-12-24

Lead Sponsor: BioMérieux

Target Recruit Count: 900

Registration Number: NCT06449183

Locations: 🇺🇸
Orlando Health, Orlando, Florida, United States
🇺🇸
Wayne State University, Detroit, Michigan, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 2 locations

Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa

Not Applicable

Completed

Conditions: Dengue
Malaria
Chikungunya

Interventions: Diagnostic Test: VIDAS® Dengue Antigen NS1, VIDAS® Anti-Dengue IgM, VIDAS® Anti-Dengue IgG, VIDAS® Anti-Chikungunya IgM and VIDAS® Anti-Chikungunya IgG
Other: Standard of care practices

First Posted Date: 2024-02-14

Last Posted Date: 2025-02-11

Lead Sponsor: BioMérieux

Target Recruit Count: 804

Registration Number: NCT06257810

Locations: 🇨🇮
CHU Cocody, Abidjan, Cocody, Côte D'Ivoire
🇨🇮
CHU Treichville, Abidjan, Treichville, Côte D'Ivoire
🇧🇫
Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso

LUNG INFECTION in ICU (LUNG-I3)

Recruiting

Conditions: VAP - Ventilator Associated Pneumonia

First Posted Date: 2023-10-10

Last Posted Date: 2025-02-12

Lead Sponsor: BioMérieux

Target Recruit Count: 68

Registration Number: NCT06073834

Locations: 🇫🇷
Hopital Edouard Herriot, Lyon, France

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

Completed

Conditions: Acute Kidney Injury
Stage 2 Acute Kidney Injury
Stage 3 Acute Kidney Injury

Interventions: Diagnostic Test: VIDAS® NEPHROCLEAR™ CCL14 Test

First Posted Date: 2023-09-14

Last Posted Date: 2024-02-28

Lead Sponsor: BioMérieux

Target Recruit Count: 477

Registration Number: NCT06036758

Locations: 🇺🇸
George Washington University, Washington, District of Columbia, United States
🇺🇸
University of Illinois, Chicago, Illinois, United States

VIDAS® NEPHROCLEAR Reference Interval Study

Completed

Conditions: Healthy

First Posted Date: 2023-09-14

Last Posted Date: 2024-02-28

Lead Sponsor: BioMérieux

Target Recruit Count: 585

Registration Number: NCT06037109

Locations: 🇺🇸
George Washington University, Washington, District of Columbia, United States
🇺🇸
University of Illinois Chicago, Chicago, Illinois, United States

VIDAS Nephroclear (NCL) CCL14 - Sample Stability

Completed

Conditions: Acute Kidney Injury

First Posted Date: 2022-03-09

Last Posted Date: 2023-09-11

Lead Sponsor: BioMérieux

Target Recruit Count: 40

Registration Number: NCT05271617

Locations: 🇺🇸
East Carolina University, Greenville, North Carolina, United States

Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis

Completed

Conditions: TUBERCULOSIS, PULMONARY

Interventions: Diagnostic Test: ISIT-TB prototype

First Posted Date: 2021-08-09

Last Posted Date: 2024-03-08

Lead Sponsor: BioMérieux

Target Recruit Count: 722

Registration Number: NCT04995406

Locations: 🇿🇦
University of Cape Town Lung Institute, Cape Town, South Africa

A Study Looking At the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients with Sepsis (Limiting AKI Progression in Sepsis)

Not Applicable

Terminated

Conditions: Sepsis
Septic Shock
Acute Kidney Injury

Interventions: Device: Subject management guided by NephroCheck® test
Other: Standard of Care

First Posted Date: 2020-06-16

Last Posted Date: 2025-02-20

Lead Sponsor: BioMérieux

Target Recruit Count: 19

Registration Number: NCT04434209

Locations: 🇺🇸
LSU Health Sciences Center, 1541 Kings Highway, Shreveport, Louisiana, United States
🇺🇸
Brigham and Womens Hospital, 75 Francis Street, Boston, Massachusetts, United States
🇧🇪
Hôpital Erasme, Soins Intensifs, Route de Lennik 808, Bruxelles, Belgium

and more 9 locations

Early Identification of SEPsis SIGNs in Emergency Department

Completed

Conditions: Infection
Sepsis

First Posted Date: 2020-02-10

Last Posted Date: 2023-06-01

Lead Sponsor: BioMérieux

Target Recruit Count: 815

Registration Number: NCT04261621

Locations: 🇫🇷
CH de Montauban, Montauban, France
🇫🇷
Hôpital Saint-Antoine AP-HP, Paris, France
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 9 locations

Performance Evaluation of the VIDAS TB-IGRA Assay.

Completed

Conditions: Latent Tuberculosis Infection
Non-Tuberculous Mycobacterial (NTM) Pneumonia
Active Tuberculosis

Interventions: Diagnostic Test: Blood draw and IGRA test

First Posted Date: 2019-08-07

Last Posted Date: 2021-07-16

Lead Sponsor: BioMérieux

Target Recruit Count: 2401

Registration Number: NCT04048018

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇬🇪
National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia
🇮🇳
Hinduja Hospital, Mumbai, India

and more 21 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy